edotreotide has been researched along with Glioma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curiel, DT; de Jong, M; Hemminki, A; Hoeben, RC; Krenning, EP; Rabelink, MJ; Sillevis Smith, PA; Verwijnen, SM; Wiebe, L | 1 |
| Freitag, P; Gratzl, O; Hausmann, O; Jermann, E; Mäcke, HR; Merlo, A; Müller-Brand, J; Otte, A; Reubi, JC; Steiner, P; Wasner, M | 1 |
| Eichhorn, K; Freitag, P; Gratzl, O; Hofer, S; Maecke, R; Merlo, A; Mueller-Brand, J; Probst, A; Reubi, JC; Schumacher, T; Wasner, M; Zimmerer, S | 1 |
2 trial(s) available for edotreotide and Glioma
| Article | Year |
|---|---|
Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas.
Topics: Adult; Astrocytoma; Binding, Competitive; Brain Edema; Brain Neoplasms; Diffusion; Disease Progression; Female; Glioblastoma; Glioma; Humans; Injections, Intralesional; Male; Middle Aged; Neoplasm Proteins; Octreotide; Oligodendroglioma; Pilot Projects; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Receptors, Somatostatin; Stereotaxic Techniques; Tissue Distribution; Ytterbium | 1999 |
Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study.
Topics: Adult; Aged; Brachytherapy; Brain Neoplasms; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Injections, Intralesional; Magnetic Resonance Imaging; Male; Middle Aged; Octreotide; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Adjuvant; Receptors, Somatostatin; Sensitivity and Specificity; Treatment Outcome; World Health Organization; Yttrium Radioisotopes | 2002 |
1 other study(ies) available for edotreotide and Glioma
| Article | Year |
|---|---|
Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 gene.
Topics: Adenoviridae; Animals; Cell Line, Tumor; Genetic Therapy; Genetic Vectors; Glioma; Herpesvirus 1, Human; Humans; Indium Radioisotopes; Iodine Radioisotopes; Nucleosides; Octreotide; Radionuclide Imaging; Rats; Receptors, Somatostatin; Thymidine Kinase; Transfection | 2004 |